Aluminium Adjuvants In Vaccinations: How Do They Really Work?

Main Category: Immune System / Vaccines
Also Included In: Biology / Biochemistry;  Preventive Medicine
Article Date: 04 Mar 2010 - 3:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:4 and a half stars

4.5 (2 votes)

Healthcare Prof:1 and a half stars

1.5 (4 votes)


An imminent publication in Trends in Immunology by a leading researcher in the bioinorganic chemistry of aluminium, Dr Christopher Exley, Reader in Bioinorganic Chemistry at The Birchall Centre, Keele University in Staffordshire, has now gone some way to giving the fullest possible explanation of how aluminium adjuvants work in boosting the immune response to vaccination.

Adjuvants are used in vaccinations to improve the efficacy of the vaccine. They enhance the immune response to the vaccine. For almost 80 years the most common form of clinically approved adjuvant has been aluminium salts. They are used in the majority of vaccines including vaccines against cervical cancer (HPV), hepatitis, polio, tetanus, diptheria and seasonal flu amongst many others. In spite of the widespread use of aluminium-based adjuvants there is very little understanding of how they actually work. A recent flurry of research papers purported to explain their mode of action though it quickly became clear that the story was still significantly confused.

The Opinion article in the prestigious review journal has explained the likely mode of action of aluminium adjuvants in the context of both the bioinorganic chemistry and immunobiology of aluminium. It has helped to explain why previous suggestions as how aluminium adjuvants work are probably not applicable to the clinically approved aluminium adjuvants used in human vaccination programmes. In doing so the article highlights the potential for aluminium and aluminium salts to stimulate the immune system and makes some reference to the possible role of aluminium adjuvants in vaccine-related diseases. The latter, though their aetiologies are largely unexplained, seem often to be linked to aluminium adjuvants.

Source: Keele University

Article adapted by Medical News Today from original press release.
Visit our immune system / vaccines section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Keele University. "Aluminium Adjuvants In Vaccinations: How Do They Really Work?." Medical News Today. MediLexicon, Intl., 4 Mar. 2010. Web.
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/181138.php>

APA
Keele University. (2010, March 4). "Aluminium Adjuvants In Vaccinations: How Do They Really Work?." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/181138.php.

Please note: If no author information is provided, the source is cited instead.


Immune System / Vaccines

Most Popular Articles



Follow Our Immune System News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Immune System / Vaccines Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »